Connecting Urethra, stricture to Military Service
Genitourinary conditions — including kidney disease, bladder disorders, and many cancers — are frequently claimed through toxic exposure pathways. Veterans exposed to Agent Orange, burn pits, contaminated water (Camp Lejeune), or PFAS from firefighting foam (AFFF) face elevated rates of genitourinary and urologic cancers under medical research. The PACT Act of 2022 significantly expanded presumptive status for many of these conditions. Urethra, stricture may also be claimed directly through service-related physical trauma or secondarily through service-connected primary conditions.
How VA Rates Urethra, stricture
The VA rates Urethra, stricture based on functional impairment — kidney function (creatinine, GFR), voiding frequency, continence, or the severity of cancer at diagnosis. For most cancers, an active malignancy is rated at 100%, with ratings adjusted after treatment completion based on residual functional impairment. Kidney conditions are rated based on nitrogen levels, residual dysfunction, and the need for dialysis.
Diagnostic Code: 7518 — Urethra, strictureis evaluated under 38 CFR Part 4 using this code. Ratings are determined at your Compensation & Pension (C&P) exam and confirmed in your rating decision letter.
Evidence Required for Your Urethra, stricture Claim
- Diagnosis from a urologist, nephrologist, or oncologist with complete medical records
- Deployment records to Vietnam (Agent Orange), Camp Lejeune, or Southwest Asia (PACT Act)
- Documentation of AFFF firefighting foam exposure if applicable (PFAS/AFFF presumptive)
- Lab results documenting kidney function (creatinine, BUN, GFR) for renal conditions
- Cancer staging, pathology reports, and treatment records for cancer claims
- Nexus letter from your treating specialist connecting the condition to service exposures
Frequently Asked Questions — Urethra, stricture and VA Disability
How does the VA rate Urethra, stricture?
Active malignancies (cancers) are rated at 100% for the duration of active treatment and for six months after. Once treatment is complete, the residual effects — kidney function loss, disability from surgery, continence issues — are rated based on their functional impact. Kidney disease and other non-cancer genitourinary conditions are rated based on laboratory values and the severity of functional impairment, ranging from 0% to 100%.
Is Urethra, stricture covered by the PACT Act or Agent Orange presumptives?
Many genitourinary cancers and conditions have presumptive service connection under Agent Orange, Camp Lejeune, or PACT Act provisions. Prostate cancer and bladder cancer are both recognized Agent Orange presumptives. The PACT Act added additional cancers to the presumptive list for veterans with burn pit exposure. Veterans should check VA's official presumptive conditions list and consult a VSO to determine whether presumptive claims apply to their specific condition and exposure history.
What evidence does VA need for a Urethra, stricture claim?
For cancer or serious disease: (1) pathology or biopsy confirming diagnosis, (2) deployment or service records establishing exposure (for presumptive claims), (3) complete treatment records, including surgery, chemotherapy, or radiation. For non-cancer conditions: (1) specialist diagnosis, (2) lab results documenting functional impairment, (3) a nexus letter. Presumptive claims do not require a nexus letter — deployment documentation alone may establish service connection.
Can Urethra, stricture be filed as a secondary condition?
Yes. Many genitourinary conditions can be secondary to service-connected conditions. For example, service-connected PTSD medication side effects, MST-related trauma, or hypertension can contribute to kidney disease or erectile dysfunction. A physician's nexus letter explaining the causal relationship between the primary service-connected condition and your urethra, stricture is required for secondary service connection claims.